newsfilter
← Latest News
GlobeNewswire·

Reunion Neuroscience Inc. Shareholders Approve Proposed Plan of Arrangement

TORONTO, July 13, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX:REUN, NASDAQ:REUN) ("Reunion" or the "Company"), a clinical-stage biopharmaceutical company committed to developing innovative and